Harrell W. Chesson
Centers for Disease Control and Prevention
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Harrell W. Chesson.
Perspectives on Sexual and Reproductive Health | 2004
Harrell W. Chesson; John M. Blandford; Thomas L. Gift; Guoyu Tao; Kathleen L. Irwin
CONTEXT Each year, millions of U.S. youth acquire sexually transmitted diseases (STDs). Estimates of the economic burden of STDs can help to quantify the impact of STDs on the nations youth and on the payers of the cost of their medical care. METHODS We synthesized the existing literature on STD costs to estimate the lifetime medical cost per case of eight major STDs-HIV, human papillomavirus (HPV), genital herpes simplex virus type 2, hepatitis B, chlamydia, gonorrhea, trichomoniasis and syphilis. We then estimated the total burden of disease by multiplying these cost-per-case estimates by the approximate number of new cases of STDs acquired by youth aged 15-24. RESULTS The total estimated burden of the nine million new cases of these STDs that occurred among 15-24-year-olds in 2000 was
Sexually Transmitted Diseases | 2013
Kwame Owusu-Edusei; Harrell W. Chesson; Thomas L. Gift; Guoyu Tao; Reena Mahajan; Marie Cheryl Bañez Ocfemia; Charlotte K. Kent
6.5 billion (in year 2000 dollars). Viral STDs accounted for 94% of the total burden (
Vaccine | 2011
Harrell W. Chesson; Donatus U. Ekwueme; Mona Saraiya; Eileen F. Dunne; Lauri E. Markowitz
6.2 billion), and nonviral STDs accounted for 6% of the total burden (
Theory and Decision | 1999
W. Kip Viscusi; Harrell W. Chesson
0.4 billion). HIV and HPV were by far the most costly STDs in terms of total estimated direct medical costs, accounting for 90% of the total burden (
The Journal of Law and Economics | 2000
Harrell W. Chesson; Paul Harrison; William J. Kassler
5.9 billion). CONCLUSIONS The large number of infections acquired by persons aged 15-24 and the high cost per case of viral STDs, particularly HIV, create a substantial economic burden.
Emerging Infectious Diseases | 2008
Harrell W. Chesson; Donatus U. Ekwueme; Mona Saraiya; Lauri E. Markowitz
Background Millions of cases of sexually transmitted infections (STIs) occur in the United States each year, resulting in substantial medical costs to the nation. Previous estimates of the total direct cost of STIs are quite dated. We present updated direct medical cost estimates of STIs in the United States. Methods We assembled recent (i.e., 2002–2011) cost estimates to determine the lifetime cost per case of 8 major STIs (chlamydia, gonorrhea, hepatitis B virus, human immunodeficiency virus (HIV), human papillomavirus, genital herpes simplex virus type 2, trichomoniasis and syphilis). The total direct cost for each STI was computed as the product of the number of new or newly diagnosed cases in 2008 and the estimated discounted lifetime cost per case. All costs were adjusted to 2010 US dollars. Results Results indicated that the total lifetime direct medical cost of the 19.7 million cases of STIs that occurred among persons of all ages in 2008 in the United States was
Vaccine | 2012
Harrell W. Chesson; Donatus U. Ekwueme; Mona Saraiya; Meg Watson; Douglas R. Lowy; Lauri E. Markowitz
15.6 (range,
Journal of Acquired Immune Deficiency Syndromes | 2000
Harrell W. Chesson; Steven D. Pinkerton
11.0–
Hepatology | 2015
Andrew J. Leidner; Harrell W. Chesson; Fujie Xu; John W. Ward; Philip R. Spradling; Scott D. Holmberg
20.6) billion. Total costs were as follows: chlamydia (
Sexually Transmitted Diseases | 2004
Harrell W. Chesson; John M. Blandford; Steven D. Pinkerton
516.7 [
Collaboration
Dive into the Harrell W. Chesson's collaboration.
National Center for Immunization and Respiratory Diseases
View shared research outputs